BoD & SCAP LOGIN

Partners & Exhibitors

Many thanks to the following companies for providing grants in support of the medical education portion of the 2023 APA Scientific Conference:


 

 

ExhibitorsDescription

The APA Foundation was created in 2008 to raise funds for education and research in the field of mental health. Your donations will help the APA Foundation bring noted speakers to present at future APA Conferences while still keeping registration fees low so as to encourage full industry participation and education

https://albertapsych.org/foundation/

Eisai is a R&D company that seeks innovative solutions in disease prevention, treatment, and care in Neurology and Oncolgy. Dayvigo is the first Orexin receptor antagonist indicated for the treatment of Insomnia in Canada with over 3.5 million patients worldwide.

https://ca.eisai.com/en-CA

Elvium Life Sciences is a pharmaceutical company passionately committed to improving the health and quality of life of Canadians through innovative medicines in specific therapeutic disease areas of need and importance. Elvium Life Sciences focuses on our existing products in the areas of CNS (ADHD) and ophthalmic conditions while continuing to seek to deliver new therapies to meet the needs of Canadians.

https://elvium.ca/

HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycle during and post exclusivity, providing access to treatments, devices and diagnostics critical to Health Care Providers, patients and their caregivers with the brand names they trust.

www.hlstherapeutics.com

We know the brain.

Lundbeck is uncompromisingly committed to the research, development and delivery of targeted therapies for people living with significant psychiatric and neurological disorders. We believe life is too beautiful to be interrupted by brain disorders. So, we pursue imaginative solutions, driven by passionate people committed to do the right thing for our patients, our company and our communities. For Lundbeck, making a meaningful difference for those with lived experience is more than an aspiration: it is a commitment that shapes everything we do. Our advocacy is at the core of who we are and motivates every individual at Lundbeck. Our ongoing engagement with patient communities is not what you might expect from a pharmaceutical company - we work with organizations to help empower people. We believe in challenging the status quo, because Canadians living with brain disorders deserve better.

http://www.lundbeck.com

Combining MD Financial Management’s unparalleled understanding of physicians’ financial needs with Scotiabank’s deep banking expertise allows us to provide a robust suite of comprehensive financial services tailored specifically to physicians’ needs and circumstances, including the uniquely co-created Scotiabank Healthcare+ Physician Banking Program.

https://mdm.ca/md-financial-management

Viatris is the sole provider of clozapine originator brand in all countries outside of North America – allowing us to share the best clozapine practices worldwide. In Canada, Viatris markets Gen-Clozapine and has provided exceptional patient care through our Gen-Clozapine Access Network (GenCAN) for over 18 years.

https://www.viatris.com/en